Temple's $54M Device: Revolutionizing Cognitive Performance MonitoringTemple's $54M Device: Revolutionizing Cognitive Performance Monitoring
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started
š——š—²š—²š—½š—¶š—»š—±š—²š—æ š—šš—¼š˜†š—®š—¹ š—æš—®š—¶š˜€š—²š—± $šŸ±šŸ°š—  š—³š—¼š—æ š—® š—±š—²š˜ƒš—¶š—°š—² š˜š—µš—®š˜ š˜€š—¶š˜š˜€ š—¼š—» š˜†š—¼š˜‚š—æ š—³š—¼š—æš—²š—µš—²š—®š—±. š— š—¼š˜€š˜ š—½š—²š—¼š—½š—¹š—² š˜š—µš—¶š—»š—ø š—¶š˜'š˜€ š—® š—Ŗš—µš—¼š—¼š—½ š—°š—¼š—ŗš—½š—²š˜š—¶š˜š—¼š—æ. š—œš˜'š˜€ š—»š—¼š˜. š—œš˜'š˜€ š˜€š—¼š—ŗš—²š˜š—µš—¶š—»š—“ š˜€š˜š—æš—®š—»š—“š—²š—æ. Here's what Temple actually is šŸ‘‡ It doesn't measure heart rate. It doesn't measure steps. It doesn't measure sleep. It measures cerebral blood flow — how blood reaches your brain in real-time. That single design choice changes everything. Why the temple, not the wrist? → Wrist & finger = biologically noisy → Temple = thinnest point of the skull → Closest clean read to intracranial signal This isn't better software on the same data. It's a different signal entirely. Why this isn't a Whoop story: Whoop owns recovery. Oura owns sleep. Apple Watch owns notifications. Ultrahuman owns metabolic. Temple is staking a claim no one else has: Cognitive performance. A category that doesn't exist at the consumer layer yet. The playbook is textbook category creation: Ship 100 units to athletes, founders, doctors, scientists Let them validate the science publicly Sell into pro sports, F1, surgical programs, special forces Launch consumer premium at $800-1500 by 2028 This isn't D2C. It's belief-first distribution. But here's the honest risk: The brain is designed to keep blood flow stable. Whether a skin-mounted sensor can detect meaningful variation — and whether that variation actually predicts performance — is unproven. The first 100 units aren't customers. They're a clinical validation study disguised as a product launch. The bigger signal for India: This isn't a diaspora founder building in San Francisco. Temple is: India-based India-manufactured (Zetwerk, Ethereal Machines) Globally aimed The Indian unicorn alumni are now building frontier hardware. That shift is bigger than the product itself. The bottom line: Temple isn't undervalued at $190M if cerebral blood flow becomes the next consumer health metric. It's a write-down if it doesn't. The probability of "yes" is non-trivial but unproven. That's exactly what makes it worth watching. Would you wear something that reads your brain to optimize your day? Or is this a metric too far?
Post image
Back to feed
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started